Actinium Pharmaceuticals ... (ATNM)
AMEX: ATNM
· Real-Time Price · USD
1.69
0.04 (2.42%)
At close: Aug 15, 2025, 3:59 PM
1.69
0.00%
After-hours: Aug 15, 2025, 05:56 PM EDT
Actinium Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 59.93M | 65.33M | 72.9M | 78.66M | 86.04M | 84.06M | 76.68M | 82.98M | 91.28M | 94.52M | 108.91M | 111.81M | 116.33M | 72.02M | 77.83M | 82.03M | 81.91M | 72.25M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 329K | 327K | 324K | 322K | 318K | 316K | 313K | 310K | 307K | n/a | 302K | 300K | n/a | n/a | n/a | 392K | 392K | 392K |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 304K | n/a | n/a | 299K | n/a | n/a | 50K | 50K | 50K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.1M | n/a | 357K | 860K | 1.03M | 1.32M | n/a | 2.62M | 4.26M | 399K | 396K | 394K | 442K | 442K | 442K | 48K | 48K | 48K |
Total Current Assets | 61.03M | 66.46M | 74.51M | 79.52M | 87.07M | 85.37M | 78.26M | 85.6M | 95.54M | 98.55M | 110.94M | 113.42M | 118.3M | 74.05M | 79.75M | 83.26M | 83.17M | 73.75M |
Property-Plant & Equipment | 1.66M | 1.86M | 2.07M | 2.27M | 2.48M | 2.66M | 2.87M | 3.04M | 3.21M | 3.18M | 2.95M | 3.09M | 3.2M | 509K | 639K | 776K | 841K | 908K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.99M | 2.19M | 2.39M | 2.59M | 2.79M | 2.98M | 3.18M | 3.35M | 3.51M | 3.48M | 3.25M | 3.39M | 3.5M | 509K | 639K | 1.22M | 1.28M | 1.35M |
Total Assets | 63.02M | 68.65M | 76.9M | 82.11M | 89.86M | 88.35M | 81.44M | 88.94M | 99.05M | 102.03M | 114.19M | 116.82M | 121.8M | 74.56M | 80.39M | 84.48M | 84.45M | 75.1M |
Account Payables | 7.71M | 6.52M | 7.57M | 7.2M | 9.18M | 7.51M | 7.95M | 8.15M | 8.64M | n/a | 10.13M | 7.87M | 5.77M | 5.26M | 5.54M | 3.77M | 3.43M | 3.73M |
Deferred Revenue | 35M | n/a | n/a | n/a | n/a | 35M | -541K | n/a | 35M | n/a | 35M | 91K | 204K | -5.26M | 998K | -3.77M | -3.43M | -3.73M |
Short-Term Debt | 600K | n/a | n/a | n/a | n/a | 551K | 541K | 522K | 514K | n/a | 498K | 390K | 311K | 195K | 307K | 417K | 447K | 437K |
Other Current Liabilities | -35M | n/a | n/a | n/a | n/a | -35.55M | n/a | -522K | -514K | 7.36M | -498K | -390K | -311K | 72K | 691K | -417K | -447K | -437K |
Total Current Liabilities | 8.31M | 7.11M | 8.15M | 7.75M | 9.73M | 8.06M | 8.49M | 8.67M | 9.15M | 7.86M | 10.63M | 8.35M | 6.28M | 5.72M | 6.84M | 4.19M | 3.87M | 4.16M |
Long-Term Debt | 690K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 35.69M | 35.84M | 35.99M | 36.15M | 36.3M | 36.43M | 36.57M | 36.69M | 36.82M | 36.95M | 37.08M | 37.21M | 37.34M | 2K | 3K | 4K | 82K | 197K |
Total Liabilities | 44M | 42.95M | 44.14M | 43.91M | 46.03M | 44.49M | 45.07M | 45.36M | 45.97M | 44.82M | 47.71M | 45.56M | 43.62M | 5.72M | 6.84M | 4.19M | 3.96M | 4.36M |
Total Debt | 1.29M | 1.43M | 1.57M | 1.71M | 1.85M | 1.98M | 2.11M | 2.21M | 2.34M | 2.46M | 2.58M | 2.6M | 2.65M | 197K | 310K | 421K | 529K | 634K |
Common Stock | 31K | 31K | 31K | 31K | 31K | 29K | 28K | 27K | 27K | 26K | 26K | 25K | 25K | 22K | 22K | 22K | 21K | 19K |
Retained Earnings | -398.64M | -391.76M | -375.83M | -369.17M | -357.61M | -346.25M | -337.58M | -328.26M | -314.98M | -299.8M | -288.76M | -278.12M | -268.64M | -260.88M | -255.75M | -247.74M | -241.31M | -236.29M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 | n/a | n/a | -0.00 | n/a | -339K | -314K |
Shareholders Equity | 19.01M | 25.69M | 32.76M | 38.21M | 43.84M | 43.86M | 36.38M | 43.58M | 53.08M | 57.21M | 66.48M | 71.25M | 78.18M | 68.84M | 73.55M | 80.28M | 80.5M | 70.74M |
Total Investments | 329K | 327K | 324K | 322K | 318K | 316K | 313K | 310K | 307K | n/a | 302K | 300K | n/a | n/a | n/a | 392K | 392K | 392K |